Ziv Neeman1, Sergio A Dromi, Shawn Sarin, Bradford J Wood. 1. Department of Diagnostic Radiology, National Institutes of Health, Clinical Center, Building 10, Room 1C 660, 10 Center Drive, Bethesda, Maryland 20892-1182, USA. zneeman@cc.nih.gov
Abstract
PURPOSE: High-radiation exposure occurs during computed tomographic (CT) fluoroscopy. Patient and operator doses during thoracic and abdominal interventional procedures were studied in the present experiment, and a novel shielding device to reduce exposure to the patient and operator was evaluated. MATERIALS AND METHODS: With a 16-slice CT scanner in CT fluoroscopy mode (120 kVp, 30 mA), surface dosimetry was performed on adult and pediatric phantoms. The shielding was composed of tungsten antimony in the form of a lightweight polymer sheet. Doses to the patient were measured with and without shielding for thoracic and abdominal procedures. Doses to the operator were recorded with and without phantom, gantry, and table shielding in place. Double-layer lead-free gloves were used by the operator during the procedures. RESULTS: Tungsten antimony shielding adjacent to the scan plane resulted in a maximum dose reduction of 92.3% to the patient. Maximum 85.6%, 93.3%, and 85.1% dose reductions were observed for the operator's torso, gonads, and hands, respectively. The use of double-layer lead-free gloves resulted in a maximum radiation dose reduction of 97%. CONCLUSIONS: Methods to reduce exposure during CT fluoroscopy are effective and should be searched for. Significant reduction in radiation doses to the patient and operator can be accomplished with tungsten antimony shielding.
PURPOSE: High-radiation exposure occurs during computed tomographic (CT) fluoroscopy. Patient and operator doses during thoracic and abdominal interventional procedures were studied in the present experiment, and a novel shielding device to reduce exposure to the patient and operator was evaluated. MATERIALS AND METHODS: With a 16-slice CT scanner in CT fluoroscopy mode (120 kVp, 30 mA), surface dosimetry was performed on adult and pediatric phantoms. The shielding was composed of tungsten antimony in the form of a lightweight polymer sheet. Doses to the patient were measured with and without shielding for thoracic and abdominal procedures. Doses to the operator were recorded with and without phantom, gantry, and table shielding in place. Double-layer lead-free gloves were used by the operator during the procedures. RESULTS:Tungsten antimony shielding adjacent to the scan plane resulted in a maximum dose reduction of 92.3% to the patient. Maximum 85.6%, 93.3%, and 85.1% dose reductions were observed for the operator's torso, gonads, and hands, respectively. The use of double-layer lead-free gloves resulted in a maximum radiation dose reduction of 97%. CONCLUSIONS: Methods to reduce exposure during CT fluoroscopy are effective and should be searched for. Significant reduction in radiation doses to the patient and operator can be accomplished with tungsten antimony shielding.
Authors: Stephen B Solomon; Alexandru Patriciu; Mark E Bohlman; Louis R Kavoussi; Dan Stoianovici Journal: Radiology Date: 2002-10 Impact factor: 11.105
Authors: Bradley L Fricke; Lane F Donnelly; Donald P Frush; Terry Yoshizumi; Vladimir Varchena; Stacy A Poe; Javier Lucaya Journal: AJR Am J Roentgenol Date: 2003-02 Impact factor: 3.959
Authors: Lifeng Yu; Xin Liu; Shuai Leng; James M Kofler; Juan C Ramirez-Giraldo; Mingliang Qu; Jodie Christner; Joel G Fletcher; Cynthia H McCollough Journal: Imaging Med Date: 2009-10
Authors: J G Alves; S Sarmento; J S Pereira; M F Pereira; M J Sousa; L Cunha; A Dias; A D Oliveira; J V Cardoso; L M Santos; J Lencart; M Gouvêa; J A M Santos Journal: Radiat Environ Biophys Date: 2019-04-16 Impact factor: 1.925
Authors: Peter Kamusella; Fabian Scheer; Christopher Wilhelm Lüdtke; Philipp Wiggermann; Christian Wissgott; Reimer Andresen Journal: J Clin Diagn Res Date: 2017-07-01
Authors: Oliver S Grosser; Christian Wybranski; Dennis Kupitz; Maciej Powerski; Konrad Mohnike; Maciej Pech; Holger Amthauer; Jens Ricke Journal: Eur Radiol Date: 2017-02-06 Impact factor: 5.315